Artificial T-Cell Receptors Market
Artificial T-Cell Receptors Market - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025 Update Available - Forecast 2024-2030
Artificial T-cell receptors provide enhanced ability to T-cells for targeting a specific protein. These receptors are often called as Chimeric Antigen Receptor (CAR) or Chimeric T-Cell Receptor which are bound to surface of T-cells and serve the purpose of alerting immune systems about the impending virus attack. The artificial T-cell receptors market is expected to grow at an impressive growth rate over the forecast period. A major factor that augments the growth of the market is the rising prevalence of cancer disease across the globe. Moreover, increasing incidence of immunological diseases and chronic diseases such as cardiovascular diseases across the globe is further fueling the market growth.
Significant prevalence of cancer disease has been observed in the US. According to the American Cancer Society in 2017, it was estimated that out of total 600,920 cancer deaths in the US, around 190,500 would be caused by cigarette smoking. In addition, it was estimated by the World Cancer Research Fund that 20% of cancers are caused by factors such as physical inactivity, excess body weight, excess alcohol consumption, and poor nutrition. Moreover, as per American Cancer Society in 2017, 87% of all the cancers in the US were diagnosed in people with age 50 years and above. However, these cancers were preventable. Additionally, colorectal and cervical cancers can be prevented by screening and by removal of precancerous lesions. Screening also has reduced the mortality rate significantly for the cancers of colon, breast, and lung. These facts and figures reflect the need for less-toxic forms of immune-based cellular therapy such as T-cell receptors therapy to treat cancer which ultimately results in positive market growth.
Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is expected to dominate the global artificial T-cell receptors market. The growth is attributed to the increasing number of cancer patients and extensive cell-based research in the region. Moreover, the presence of key players that uses artificial T-cell receptors for the development of new drugs and therapy is further supporting the market growth in the region. Europe is the expected to follow North America in terms of revenue generation due to the technological advancements in the biotechnology field. Furthermore, Asia-Pacific is considered as the fastest growing market during the forecast period. A rapidly aging population coupled with the growing number of cancer patients and high penetration of new technology are the key factors for the growth of the artificial T-cell receptors market in Asia-Pacific region.
There are various companies involved in the development of artificial T-cell receptors such as Pfizer, Inc., Thermo Fisher Scientific, Inc., Novartis AG, Eli Lilly & Co., Lonza Group Ltd., Adaptive Biotechnologies Corp., Kite Pharma, Inc., Blubird Bio, Inc., and Medigene AG. The companies are focused on developing advanced artificial T-cells receptors to stay competitive in the market. Geographical expansion, merger & acquisition, partnerships & collaborations, finding a new market or innovate in their core competency in order to expand individual market share are some of the key strategies adopted by major market players. For instance, in 2016, Medigene AG established strategic T-Cell Receptor (TCR) Alliance in Cancer Immunotherapy in which Medigene has received an upfront payment of $15 million.
Research Methodology
The market study of the global artificial T-cell receptors market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
- Financial reports of companies involved in the market
- Authentic Public Databases such as the OECD, WHO, American Cancer Society, World Cancer Research Fund and others
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
The report is intended for research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation
Global artificial T-cell receptors market is segmented on the basis of regional outlook and following segments:
- Global Artificial T-Cell Receptors Market Research and Analysis by Disease
- Global Artificial T-Cell Receptors Market Research and Analysis by Therapy
- Global Artificial T-Cell Receptors Market Research and Analysis by End-User
- Global Artificial T-Cell Receptors Market Research and Analysis by Geography
The Report Covers
- Comprehensive research methodology of the global artificial T-cell receptors market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global artificial T-cell receptors market.
- Insights about market determinants which are stimulating the global artificial T-cell receptors market
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules and Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Eli Lilly & Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Thermo Fisher Scientific, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Lonza Group Ltd.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Novartis AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. Swot Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Artificial T-Cell Receptors Market by Disease
5.1.1. Cancer
5.1.1.1. Acute Lymphoblastic Leukemia (ALL)
5.1.1.2. Diffuse Large B-Cell Lymphoma
5.1.1.3. Other Cancer Types
5.1.2. Immunological Disorders
5.2. Global Artificial T-Cell Receptors Market by Therapy
5.2.1. Autologous
5.2.2. Allogenic
5.3. Global Artificial T-Cell Receptors Market by End-User
5.3.1. Research Institutes
5.3.2. Hospitals
5.3.3. Biotech Companies
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Adaptive Biotechnologies Corp.
7.2. Athenex, Inc.
7.3. Blubird Bio, Inc.
7.4. Cabaletta Bio, Inc.
7.5. Celgene Corp.
7.6. Cell Medica Ltd.
7.7. Eli Lilly & Co.
7.8. Juno Therapeutics, Inc.
7.9. Kite Pharma, Inc.
7.10. Lonza Group Ltd.
7.11. Medicomp Systems, Inc.
7.12. Medigene AG
7.13. NexImmune Inc.
7.14. Novartis AG
7.15. Oxford BioMedica PLC
7.16. Pfizer, Inc.
7.17. Precision Biosciences, Inc.
7.18. STEMCELL Technologies Inc.
7.19. TCR² Therapeutics Inc.
7.20. Thermo Fisher Scientific, Inc.
7.21. Unum Therapeutics, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
TABLE # 2 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 3 GLOBAL IMMUNOLOGICAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 4 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
TABLE # 5 GLOBAL AUTOLOGOUS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 6 GLOBAL ALLOGENIC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 7 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
TABLE # 8 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 9 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 10 GLOBAL BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 11 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
TABLE # 12 NORTH AMERICAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 13 NORTH AMERICAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
TABLE # 14 NORTH AMERICAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
TABLE # 15 NORTH AMERICAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
TABLE # 16 EUROPEAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 17 EUROPEAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
TABLE # 18 EUROPEAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
TABLE # 19 EUROPEAN ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
TABLE # 20 ASIA-PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 21 ASIA-PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
TABLE # 22 ASIA-PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
TABLE # 23 ASIA-PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
TABLE # 24 REST OF THE WORLD ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
TABLE # 25 REST OF THE WORLD ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
TABLE # 26 REST OF THE WORLD ARTIFICIAL T-CELL RECEPTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET SHARE BY DISEASE, 2018 VS 2025 (%)
FIGURE # 2 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET SHARE BY THERAPY, 2018 VS 2025 (%)
FIGURE # 3 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET SHARE BY END-USER, 2018 VS 2025 (%)
FIGURE # 4 GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
FIGURE # 5 US ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 6 CANADA ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 7 UK ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 8 FRANCE ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 9 GERMANY ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 10 ITALY ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 11 SPAIN ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 12 ROE ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 13 INDIA ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 14 CHINA ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 15 JAPAN ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 17 REST OF THE WORLD ARTIFICIAL T-CELL RECEPTORS MARKET SIZE, 2018-2025 ($ MILLION)
